The FDA will not enforce certain Drug Supply Chain Security Act requirements for public health programs that distribute naloxone to underserved communities while the opioid public health emergency declaration is in effect, the agency said in guidance released Sept. 22.
The guidance comes about five months after President Joe Biden shared a formal plan with Congress to address the nation’s addiction and drug overdose crisis, part of which called for increasing access to naloxone.
View the FDA’s full guidance here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.